Clinical Trial Update: Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure

View source ↗

Summary

The trial update warns of the risk of hepatitis B reactivation in patients who have prior exposure to hepatitis B virus undergoing bone marrow transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: The University of Hong Kong | Conditions: Exposure to Hepatitis B Virus | Status: COMPLETED